Characterization of DNA topoisomerase I in three SN-38 resistant human colon cancer cell lines reveals a new pair of resistance-associated mutations

BACKGROUND: DNA topoisomerase I (Top1) is a DNA unwinding protein and the specific target of the camptothecin class of chemotherapeutic drugs. One of these, irinotecan, acting through its active metabolite SN-38, is used in the treatment of metastatic colorectal cancer. However, resistance to irinot...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Niels Frank, Agama, Keli, Roy, Amit, Smith, David Hersi, Pfister, Thomas D., Rømer, Maria Unni, Zhang, Hong-Liang, Doroshow, James H., Knudsen, Birgitta R., Stenvang, Jan, Brünner, Nils, Pommier, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815242/
https://www.ncbi.nlm.nih.gov/pubmed/27029323
http://dx.doi.org/10.1186/s13046-016-0335-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815242/
https://www.ncbi.nlm.nih.gov/pubmed/27029323
http://dx.doi.org/10.1186/s13046-016-0335-x

Ejemplares similares